Mr Thomas Mitchell, FRCS
Clinician Scientist Fellow
Tom Mitchell's research programme focusses on understanding how kidney tumours initiate, evolve and evade treatment. The motivation for this body of work is provided by the patients he treats as a Consultant Urologist at Addenbrooke's Hospital where he specialises in the surgical treatment of kidney cancer.
I am interested in deciphering how tumours evolve over many decades from normal healthy cells. Increasingly, my interest lies not only in understanding and modelling somatic mutations acquired in the developing tumour, but also how these cancer cells interact with their multi-cellular micro-environment. The over-arching aim of these approaches is to improve the clinical management of patients with cancer.
Cancer Research UK/ Royal College of Surgeons Clinician Scientist Fellowship, Wellcome Sanger Institute
Honorary Consultant Urologist, Addenbrooke's Hospital
FRCS (Urol): Fellowship of the Royal College of Surgeons of England
Academic Clinical Lecturer, Cambridge University
Honorary Specialist Registrar, Addenbrooke's Hospital
Academic Clinical Fellow, Cambridge University
Core Surgical Trainee, Gloucestershire NHS Foundation Trust
Foundation Doctor, Gloucestershire NHS Foundation Trusts
BMBCh, Bachelor of Medicine and Surgery, University of Oxford
DPhil, Doctorate of Philosophy in Engineering Science, University of Oxford
Programmes and Facilities
We are focused on using single-cell approaches, so called “cell atlas” technologies and understanding human genetics at the cellular level. The ...